Cardiomyopathy in transgenic myf5 mice

Circulation Research
J G EdwardsL A Leinwand

Abstract

To explore the compatibility of skeletal and cardiac programs of gene expression, transgenic mice that express a skeletal muscle myogenic regulator, bmyf5, in the heart were analyzed. These mice develop a severe cardiomyopathy and exhibit a significantly shorter life span than do their nontransgenic littermates. The transgene was expressed from day 7.5 post coitum forward, resulting in activation of skeletal muscle genes not normally seen in the myocardium. Cardiac pathology was not apparent at midgestation but was evident by day 2 of postnatal life, and by 42 days, hearts exhibited multifocal interstitial inflammation, fibrosis, cellular hypertrophy, and occasional myocyte degeneration. All four chambers of the heart were enlarged to varying degrees, with the atria demonstrating the most significant hypertrophy (>100% in 42-day-old mice). The transgene and several skeletal muscle-specific genes were expressed only in patchy areas of the heart in heterozygous mice. However, molecular markers of hypertrophy (such as alpha-skeletal actin and atrial myosin light chain- 1) were expressed with a wider distribution, suggesting that their induction was secondary to the expression of the transgene, In older (28-week-old) mice, lung wei...Continue Reading

References

Sep 1, 1979·European Journal of Biochemistry·A d'AlbisJ J Bechet
Feb 1, 1992·Cardiovascular Research·A MalhotraR Aronson
Oct 1, 1990·The Journal of Cell Biology·G E LyonsM Buckingham
Dec 1, 1990·The Journal of Cell Biology·G E LyonsM Buckingham
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H WeintraubA D Miller
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C E SeidmanJ G Seidman
Feb 1, 1985·Journal of Molecular and Cellular Cardiology·A MalhotraJ Scheuer
Sep 1, 1985·The Journal of Cell Biology·S A LewisN J Cowan
Aug 6, 1971·Biochimica Et Biophysica Acta·R J SolaroF N Briggs
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·I Komuro, S Izumo
May 1, 1995·Molecular and Cellular Biology·P S NaiduS F Konieczny
Jan 1, 1994·Journal of Molecular and Cellular Cardiology·P M ButtrickJ Scheuer
Oct 1, 1993·Molecular and Cellular Biology·R F SanterreC K Smith
Apr 1, 1993·Developmental Biology·J LitvinD M Bader

❮ Previous
Next ❯

Citations

Apr 15, 2008·Trends in Endocrinology and Metabolism : TEM·B J Wedel, D L Garbers
Jun 30, 1998·Izvestiia Akademii nauk. Seriia biologicheskaia·N D Ozerniuk
Oct 27, 2001·Acta Physiologica Scandinavica·Y Takeishi, R A Walsh
Apr 1, 1999·Annual Review of Physiology·P D Kessler, B J Byrne
May 17, 2000·The Journal of Clinical Investigation·K R Chien
Feb 14, 1998·The Journal of Clinical Investigation·M A SussmanT R Kimball
Nov 15, 1996·The Journal of Clinical Investigation·C E MurryS M Schwartz
Jun 17, 1998·The Journal of Clinical Investigation·R C FentzkeJ M Leiden
Apr 25, 2000·Journal of Molecular and Cellular Cardiology·J D BisognanoD J Port
Jan 30, 1999·Journal of Cardiac Failure·V J Kadambi, E G Kranias
Oct 28, 2016·Heart Failure Reviews·Alexander T Mikhailov, Mario Torrado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.